Literature DB >> 20849372

Neuronal activity controls the antagonistic balance between peroxisome proliferator-activated receptor-γ coactivator-1α and silencing mediator of retinoic acid and thyroid hormone receptors in regulating antioxidant defenses.

Francesc X Soriano1, Frédéric Léveillé, Sofia Papadia, Karen F S Bell, Clare Puddifoot, Giles E Hardingham.   

Abstract

Transcriptional coactivators and corepressors often have multiple targets and can have opposing actions on transcription and downstream physiological events. The coactivator peroxisome proliferator-activated receptor-γ coactivator (PGC)-1α is under-expressed in Huntington's disease and is a regulator of antioxidant defenses and mitochondrial biogenesis. We show that in primary cortical neurons, expression of PGC-1α strongly promotes resistance to excitotoxic and oxidative stress in a cell autonomous manner, whereas knockdown increases sensitivity. In contrast, the transcriptional corepressor silencing mediator of retinoic acid and thyroid hormone receptors (SMRT) specifically antagonizes PGC-1α-mediated antioxidant effects. The antagonistic balance between PGC-1α and SMRT is upset in favor of PGC-1α by synaptic activity. Synaptic activity triggers nuclear export of SMRT reliant on multiple regions of the protein. Concomitantly, synaptic activity post-translationally enhances the transactivating potential of PGC-1α in a p38-dependent manner, as well as upregulating cyclic-AMP response element binding protein-dependent PGC-1α transcription. Activity-dependent targeting of PGC-1α results in enhanced gene expression mediated by the thyroid hormone receptor, a prototypical transcription factor coactivated by PGC-1α and repressed by SMRT. As a consequence of these events, SMRT is unable to antagonize PGC-1α-mediated resistance to oxidative stress in synaptically active neurons. Thus, PGC-1α and SMRT are antagonistic regulators of neuronal vulnerability to oxidative stress. Further, this coactivator-corepressor antagonism is regulated by the activity status of the cell, with implications for neuronal viability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20849372      PMCID: PMC3044457          DOI: 10.1089/ars.2010.3568

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  50 in total

1.  The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export.

Authors:  S H Hong; M L Privalsky
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.

Authors:  Libin Cui; Hyunkyung Jeong; Fran Borovecki; Christopher N Parkhurst; Naoko Tanese; Dimitri Krainc
Journal:  Cell       Date:  2006-10-06       Impact factor: 41.582

3.  Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

Authors:  Patrick Weydt; Victor V Pineda; Anne E Torrence; Randell T Libby; Terrence F Satterfield; Eduardo R Lazarowski; Merle L Gilbert; Gregory J Morton; Theodor K Bammler; Andrew D Strand; Libin Cui; Richard P Beyer; Courtney N Easley; Annette C Smith; Dimitri Krainc; Serge Luquet; Ian R Sweet; Michael W Schwartz; Albert R La Spada
Journal:  Cell Metab       Date:  2006-10-19       Impact factor: 27.287

4.  Suppression of the intrinsic apoptosis pathway by synaptic activity.

Authors:  Frédéric Léveillé; Sofia Papadia; Michael Fricker; Karen F S Bell; Francesc X Soriano; Marc-André Martel; Clare Puddifoot; Marlen Habel; David J Wyllie; Chrysanthy Ikonomidou; Aviva M Tolkovsky; Giles E Hardingham
Journal:  J Neurosci       Date:  2010-02-17       Impact factor: 6.167

Review 5.  PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.

Authors:  R Bordet; T Ouk; O Petrault; P Gelé; S Gautier; M Laprais; D Deplanque; P Duriez; B Staels; J C Fruchart; M Bastide
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

6.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

7.  Dynamic inhibition of nuclear receptor activation by corepressor binding.

Authors:  Young-Chang Sohn; Seung-Whan Kim; Seunghee Lee; Young-Yun Kong; Doe Sun Na; Soo-Kyung Lee; Jae Woon Lee
Journal:  Mol Endocrinol       Date:  2002-12-18

8.  PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons.

Authors:  Przemyslaw Wareski; Annika Vaarmann; Vinay Choubey; Dzhamilja Safiulina; Joanna Liiv; Malle Kuum; Allen Kaasik
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

Review 9.  Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens.

Authors:  James W Simpkins; Kun Don Yi; Shao-Hua Yang
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606

10.  Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione.

Authors:  Francesc X Soriano; Frédéric Léveillé; Sofia Papadia; Larry G Higgins; James Varley; Paul Baxter; John D Hayes; Giles E Hardingham
Journal:  J Neurochem       Date:  2008-09-16       Impact factor: 5.372

View more
  13 in total

1.  Developmental and activity-dependent expression of LanCL1 confers antioxidant activity required for neuronal survival.

Authors:  Chao Huang; Mina Chen; Dejiang Pang; Dandan Bi; Yi Zou; Xiaoqiang Xia; Weiwei Yang; Liping Luo; Rongkang Deng; Honglin Tan; Liang Zhou; Shouyang Yu; Liheng Guo; XiaoXia Du; Yiyuan Cui; Jiahua Hu; Qing Mao; Paul F Worley; Bo Xiao
Journal:  Dev Cell       Date:  2014-08-25       Impact factor: 12.270

Review 2.  Mechanisms of specificity in neuronal activity-regulated gene transcription.

Authors:  Michelle R Lyons; Anne E West
Journal:  Prog Neurobiol       Date:  2011-05-18       Impact factor: 11.685

3.  Mitochondrial fragmentation in excitotoxicity requires ROCK activation.

Authors:  Alejandro Martorell-Riera; Marc Segarra-Mondejar; Manuel Reina; Ofelia M Martínez-Estrada; Francesc X Soriano
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Mediator subunit MED1 modulates intranuclear dynamics of the thyroid hormone receptor.

Authors:  Matthew R Femia; Rochelle M Evans; Jibo Zhang; Xiaopeng Sun; Caroline J Lebegue; Vincent R Roggero; Lizabeth A Allison
Journal:  J Cell Biochem       Date:  2019-11-06       Impact factor: 4.429

Review 5.  Thyroid hormone receptor localization in target tissues.

Authors:  Cyril S Anyetei-Anum; Vincent R Roggero; Lizabeth A Allison
Journal:  J Endocrinol       Date:  2018-02-12       Impact factor: 4.286

6.  Multiple exportins influence thyroid hormone receptor localization.

Authors:  Kelly S Subramanian; Rose C Dziedzic; Hallie N Nelson; Mary E Stern; Vincent R Roggero; Cornelius Bondzi; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2015-04-21       Impact factor: 4.102

7.  PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity.

Authors:  Clare Puddifoot; Marc-Andre Martel; Francesc X Soriano; Alberto Camacho; Antonio Vidal-Puig; David J A Wyllie; Giles E Hardingham
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

Review 8.  The influence of synaptic activity on neuronal health.

Authors:  Karen F S Bell; Giles E Hardingham
Journal:  Curr Opin Neurobiol       Date:  2011-02-01       Impact factor: 6.627

Review 9.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.

Authors:  Giles E Hardingham; Hilmar Bading
Journal:  Nat Rev Neurosci       Date:  2010-09-15       Impact factor: 34.870

10.  SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites.

Authors:  Francesc X Soriano; Sangeeta Chawla; Paul Skehel; Giles E Hardingham
Journal:  J Neurochem       Date:  2012-11-15       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.